Cargando…

Dynamic surveillance of SARS-CoV-2 shedding and neutralizing antibody in children with COVID-19

Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in China and quickly spread globally. In this study, we investigated the characteristics of viral shedding from different sites and the neutralizing antibody (NAb) response during the a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Pengcheng, Cai, Jiehao, Jia, Ran, Xia, Shuai, Wang, Xiangshi, Cao, Lingfeng, Zeng, Mei, Xu, Jin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2020
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7448895/ https://www.ncbi.nlm.nih.gov/pubmed/32515685 http://dx.doi.org/10.1080/22221751.2020.1772677

Ejemplares similares

The spike protein of SARS-CoV-2 induces inflammation and EMT of lung epithelial cells and fibroblasts through the upregulation of GADD45A
por: Cai, Jiehao, et al.
Publicado: (2023)

Epidemiological surveillance of hand, foot and mouth disease in Shanghai in 2014–2016, prior to the introduction of the enterovirus 71 vaccine
por: Li, Jingjing, et al.
Publicado: (2018)

Epidemiological and clinical features of SARS‐CoV‐2 infection in children during the outbreak of Omicron variant in Shanghai, March 7–31, 2022
por: Wang, Xiangshi, et al.
Publicado: (2022)

Comparison of Clinical and Epidemiological Characteristics of Asymptomatic and Symptomatic SARS-CoV-2 Infection in Children
por: Cai, Jiehao, et al.
Publicado: (2020)

A non-RBM targeted RBD specific antibody neutralizes SARS-CoV-2 inducing S1 shedding
por: Long, Yingyi, et al.
Publicado: (2021)

Potent Therapeutic Strategies for COVID-19 with Single-Domain Antibody Immunoliposomes Neutralizing SARS-CoV-2 and Lip/cGAMP Enhancing Protective Immunity
por: Zhou, Yajun, et al.
Publicado: (2023)

Norovirus Activity and Genotypes in Sporadic Acute Diarrhea in Children in Shanghai During 2014–2018
por: Wang, Xiangshi, et al.
Publicado: (2019)

Longitudinal sampling sheds light on SARS-CoV-2 fecal shedding dynamics
por: Coryell, Michael P., et al.
Publicado: (2022)

Rational optimization of a human neutralizing antibody of SARS-CoV-2
por: Chen, Jiao, et al.
Publicado: (2021)

SARS-CoV-2 shedding dynamics and transmission in immunosuppressed patients
por: Lee, Jee-Soo, et al.
Publicado: (2022)

Dynamics of neutralizing antibody responses to SARS-CoV-2 in patients with COVID-19: an observational study
por: Xu, Xin, et al.
Publicado: (2021)

Antibody-mediated neutralization of SARS-CoV-2
por: Gruell, Henning, et al.
Publicado: (2022)

Neutralizing antibodies for SARS-CoV-2 infection
por: Berenguer, Juan
Publicado: (2022)

A human SARS-CoV neutralizing antibody against epitope on S2 protein
por: Duan, Jinzhu, et al.
Publicado: (2005)

Enterovirus 71 infection in children with hand, foot, and mouth disease in Shanghai, China: epidemiology, clinical feature and diagnosis
por: Wang, Ying, et al.
Publicado: (2015)

Mild Cytokine Elevation, Moderate CD4(+) T Cell Response and Abundant Antibody Production in Children with COVID-19
por: Jia, Ran, et al.
Publicado: (2020)

SARS-CoV-2-specific CD4(+) T cells are associated with long-term persistence of neutralizing antibodies
por: Wang, Zhongfang, et al.
Publicado: (2022)

Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies
por: Cao, Yunlong, et al.
Publicado: (2021)

SARS-CoV-2 shedding and infectivity – Authors' reply
por: Zhou, Fei, et al.
Publicado: (2020)

SARS-CoV-2 neutralizing antibody development strategies
por: BALCIOĞLU, Bertan Koray, et al.
Publicado: (2020)

Human antibodies can neutralize SARS-CoV-2
por: Catalan-Dibene, Jovani
Publicado: (2020)

Neutralizing antibody titres in SARS-CoV-2 infections
por: Lau, Eric H. Y., et al.
Publicado: (2021)

Neutralizing and enhancing antibodies against SARS-CoV-2
por: Liu, Yafei, et al.
Publicado: (2022)

SARS-CoV-2 shedding and infectivity
por: Atkinson, Barry, et al.
Publicado: (2020)

Structural basis for neutralization of SARS-CoV-2 and SARS-CoV by a potent therapeutic antibody
por: Lv, Zhe, et al.
Publicado: (2020)

Neutralizing antibodies against SARS-CoV-2: current understanding, challenge and perspective
por: Huang, Yang, et al.
Publicado: (2020)

RBD-Fc-based COVID-19 vaccine candidate induces highly potent SARS-CoV-2 neutralizing antibody response
por: Liu, Zezhong, et al.
Publicado: (2020)

Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers
por: Vanshylla, Kanika, et al.
Publicado: (2022)

Overview of Neutralization Assays and International Standard for Detecting SARS-CoV-2 Neutralizing Antibody
por: Liu, Kuan-Ting, et al.
Publicado: (2022)

MPER-specific antibodies induce gp120 shedding and irreversibly neutralize HIV-1
por: Ruprecht, Claudia R., et al.
Publicado: (2011)

An antibody that neutralizes SARS-CoV-1 and SARS-CoV-2 by binding to a conserved spike epitope outside the receptor binding motif
por: Fang, Yan, et al.
Publicado: (2022)

Application of an integrated computational antibody engineering platform to design SARS-CoV-2 neutralizers
por: Riahi, Saleh, et al.
Publicado: (2021)

SARS-CoV-2 monoclonal antibodies with therapeutic potential: Broad neutralizing activity and No evidence of antibody-dependent enhancement
por: Wang, Ying-Ting, et al.
Publicado: (2021)

Neutralizing Antibody Response and SARS Severity
por: Ho, Mei-Shang, et al.
Publicado: (2005)

Antibody-like proteins that capture and neutralize SARS-CoV-2
por: Kondo, T., et al.
Publicado: (2020)

Perspectives on the development of neutralizing antibodies against SARS-CoV-2
por: Ho, Mitchell
Publicado: (2020)

Neutralizing antibodies targeting SARS-CoV-2 spike protein
por: Xiaojie, Shi, et al.
Publicado: (2021)

Epitope Analysis of Anti-SARS-CoV-2 Neutralizing Antibodies
por: Xue, Jun-biao, et al.
Publicado: (2021)

Multivalency transforms SARS-CoV-2 antibodies into ultrapotent neutralizers
por: Rujas, Edurne, et al.
Publicado: (2021)

Human neutralizing antibodies for SARS-CoV-2 prevention and immunotherapy
por: Zhou, Dongyan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_so6qi536150ed2m22smcdvjidp